Skip to main content may receive compensation from affiliate partners for some links on the site. Read our full Disclosure here.

Silicon Valley Investors Believe Young People’s Blood Can Stop Aging Process


What you’re about to read is truly sinister.

We’ve all read a story or watched a movie about vampires before, but what if I told you those movies and books aren’t too far-fetched.

Reports have shown investors from Silicon Valley have invested billions of dollars into biotech companies that believe young people’s blood can stop the aging process.

Neuroscientist Tony Wyss-Coray and Saul Villeda wrote in scientific papers published in 2014 that “the blood from young mice had seemingly miraculous restorative effects on the brains of elderly mice”.

Now they want to move their idea from mice to humans and have a large financial backing to do it.

If you haven’t noticed already Plasma centers and Blood Banks that offer people money for the exchange of their blood are popping up all over the country and their usually always built in areas where the income level is low or for areas where there’s a lot of college students.

Instead of imagining a vampire of a man with long fang teeth and a black coat we should imagining them as wealthy people who want eternal life outside of God.

Newsweek broke the story and had these details to share:

Earlier this year, Grifols closed on a $146 million-deal to buy Alkahest, a company founded by Stanford University neuroscientist Tony Wyss-Coray, who, along with Saul Villeda, revealed in scientific papers published in 2011 and 2014 that the blood from young mice had seemingly miraculous restorative effects on the brains of elderly mice. The discovery adds to a hot area of inquiry called geroscience that “seeks to understand molecular and cellular mechanisms that make aging a major risk factor and driver of common chronic conditions and diseases of older adulthood,” according to the National Institutes of Health. In the last six years, Alkahest has identified more than 8,000 proteins in the blood that show potential promise as therapies. Its efforts and those of Grifols have resulted in at least six phase 2 trials completed or underway to treat a wide range of age-related diseases, including Alzheimer’s and Parkinson’s.

Alkahest and a growing number of other geroscience health startups signal a change in thinking about some of the most intractable diseases facing humankind. Rather than focusing solely on the etiology of individual diseases like heart disease, cancer, Alzheimer’s and arthritis—or, for that matter, COVID-19—geroscientists are trying to understand how these diseases relate to the single largest risk factor of all: human aging. Their goal is to hack the process of aging itself and, in the process, delay or stave off the onset of many of the diseases most associated with growing old.

The idea that aging and illness go hand and hand is, of course, nothing new. What’s new is the newfound confidence of scientists that “aging” can be measured, reverse-engineered and controlled.

Although the vast majority of these efforts remain in preclinical development, several have recently entered FDA trials and could potentially hit the market in a few years. Some are already appearing on the gray market, raising concerns that hucksters are peddling anti-aging snake oil. Others, meanwhile, worry what might happen if these drugs actually do deliver on their promise: Will poor young people be coerced into selling their blood to elderly billionaires? Will magical anti-aging pills become the province of the Park Avenue and Hollywood rich, like facelifts, hair plugs and botox injections? Will the rest of us senile peasants be forced to watch them age backwards as we are left to wither and die?

The concept of the elite infusing themselves with young people’s blood has been around for years.

If you were to talk about this out loud a couple of years ago people would call you conspiracy theorists but now even the mainstream media is reporting it.

Men’s Health reported the science behind it:

Imagine an old lab mouse—the bad hair, the wrong turns in the maze, the lazing around. Now imagine that mouse surgically conjoined to another, more youthful one . . . and then seeing it, within weeks, start getting younger. When scientists did this, “they found the old mouse showed fewer diseases of aging, like diabetes, heart disease, and Alzheimer’s,” says Jesse Karmazin, M.D.

For Dr. Karmazin, the old mouse is you. This 33-year-old Stanford-trained physician has no plans to sew you to a college freshman. But he’s betting, based on recent research, that humans experience the same age-bending benefit from a
dose of young blood.

Dr. Karmazin admits it sounds totally creepy

In 2016, Dr. Karmazin founded Ambrosia, a company that will infuse you with one to two liters of a 16- to 25-year-old’s plasma. For up to $12,000. So far, he says, many of his 150 patients report feeling and performing better on just one treatment a year. He admits it sounds totally creepy, even though transfusions, of course, aren’t new science. “We’re just using them for a different purpose.”

Experiments on mouse “parabiosis,” the anatomical joining of two individuals, date back to 1864; the young mouse/old mouse findings were reported in the 1950s. But inquiries stalled until 2002, when scientists at Stanford were in a routine meeting, bullshitting about becoming old and why components of your body age in unison instead of separately. Someone tossed out a hypothesis: Your circulation reaches everything in your body, so maybe your blood holds chemicals that make you old.

If the mainstream media is reporting this science now, it means the elite have been using this practice for years.

Maybe it’s just me but most celebrities in Hollywood look extremely young and it looks like they’re doing more than just plastic surgeries to keep their youthful appearance.


Join the conversation!

Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!

Thanks for sharing!